Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Future of Medicine Lies in AI and Cloud Computing

Precision medicine, or healthcare customized to each individual patient, is almost upon us. Leading the way are innovative partnerships such as that developed between Microsoft and St. Jude’s Children’s Hospital. Clinicians and researchers are accessing genomic processing services through Microsoft Azure, a cloud computing service. It’s vital to use cloud computing because a single genome…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Precision medicine, or healthcare customized to each individual patient, is almost upon us. Leading the way are innovative partnerships such as that developed between Microsoft and St. Jude’s Children’s Hospital. Clinicians and researchers are accessing genomic processing services through Microsoft Azure, a cloud computing service. It’s vital to use cloud computing because a single genome takes up 200 gigabytes of space. As Healthcare IT News reports, “For scientists to make breakthroughs that could help lead to cures for pediatric cancers, researchers around the world need to be able to share and collaborate on genomic data. St. Jude is uploading anonymized genomes of their patients’ healthy and cancerous cells to public data repositories.

Along with cloud computing, artificial intelligence (AI) will help connect devices and records systems as well as trace population health and provide analytics.

Recently, Microsoft announced the winners of its 2018 Health Innovation Awards. This year there was a tie. One of the awards went to Kaiser Permanente and KenSci for their AI/machine learning dashboard that improves congestive heart failure management. The other went to Ochsner Health System, who is partnering with Epic to integrate AI into real-time workflows. Their new technology “sends early warning alerts by tracking and analyzing patient symptoms to predict when patients might be deteriorating. The goal is to eliminate adverse events before they happen.”

With easier access to genomics information and more precise and customized tracking and monitoring of both populations and patients, cloud computing and AI are at the forefront of revolutionizing medicine. The more doctors and clinicians can customize medicine to the precise genetics and conditions of patients, the better health care they will be able to provide each of their patients. True precision medicine may still be a concept of the future, but Microsoft is working hard to help bring that concept to fruition as quickly as possible.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512